T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVX
776
DELISTED
AVX Corporation
AVX
| $59.1M | 0.01% |
4,143,342
+133,340
| +3% | +$1.84M |
|
|
ROSE
777
DELISTED
ROSETTA RESOURCES INC
ROSE
| $58.9M | 0.01% |
3,462,795
+3,383,795
| +4,283% | +$64.8M |
|
|
DEL
778
DELISTED
Deltic Timber
DEL
| $58.8M | 0.01% |
888,108
-116,840
| -12% | -$7.6M |
|
779
ON Semiconductor
ON
$32.8B
| $58.7M | 0.01% |
4,848,300
+2,739,961
| +130% | +$31.4M |
|
780
HUB Group
HUBG
$2.58B
| $58.6M | 0.01% |
2,983,800
-1,005,520
| -25% | -$18.9M |
|
781
Comfort Systems
FIX
$61.1B
| $58.5M | 0.01% |
2,782,489
+325,090
| +13% | +$5.79M |
|
782
Diamondrock Hospitality Co
DRH
$2.51B
| $58.4M | 0.01% |
4,133,496
-208,360
| -5% | -$3.05M |
|
783
Truist Financial
TFC
$64.6B
| $58.2M | 0.01% |
1,493,622
+58,330
| +4% | +$2.2M |
|
784
Forum Energy Technologies
FET
$943M
| $58.2M | 0.01% |
148,551
+4,941
| +3% | +$1.79M |
|
785
TriMas Corp
TRS
$1.4B
| $58.2M | 0.01% |
2,372,753
-69,452
| -3% | -$1.64M |
|
786
National Bank Holdings
NBHC
$1.93B
| $58M | 0.01% |
3,084,300
+1,004,990
| +48% | +$18.6M |
|
787
Haemonetics
HAE
$4.16B
| $58M | 0.01% |
1,291,280
+6,200
| +0.5% | +$259K |
|
788
HDFC Bank
HDB
$119B
| $57.7M | 0.01% |
3,917,220
-461,072
| -11% | -$6.74M |
|
|
UTIW
789
DELISTED
UTI WORLDWIDE INC
UTIW
| $57.7M | 0.01% |
4,687,310
-4,760
| -0.1% | -$58.9K |
|
|
ZSPH
790
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $57.3M | 0.01% |
1,360,578
+691,407
| +103% | +$31.6M |
|
791
Wayfair
W
$13.9B
| $57.2M | 0.01% |
1,779,398
-628,200
| -26% | -$15.6M |
|
|
TDAY
792
USA Today Co
TDAY
$1.01B
| $57.1M | 0.01% |
2,386,946
+751,470
| +46% | +$17.4M |
|
|
WPP
793
DELISTED
WAUSAU PAPER CORP.
WPP
| $56.7M | 0.01% |
5,945,934
+369,744
| +7% | +$3.59M |
|
|
ARRY
794
DELISTED
Array Biopharma Inc
ARRY
| $56.1M | 0.01% |
7,608,100
-1,085,000
| -12% | -$7.72M |
|
795
Northrop Grumman
NOC
$81.6B
| $56M | 0.01% |
348,069
+10,180
| +3% | +$1.63M |
|
|
FARO
796
DELISTED
Faro Technologies
FARO
| $55.7M | 0.01% |
896,704
-228,506
| -20% | -$13.1M |
|
797
Albany International
AIN
$1.81B
| $55.6M | 0.01% |
1,398,883
-149,160
| -10% | -$5.57M |
|
798
Ambev
ABEV
$43.8B
| $55.6M | 0.01% |
9,646,500
-103,500
| -1% | -$643K |
|
|
LM
799
DELISTED
Legg Mason, Inc.
LM
| $55.6M | 0.01% |
1,006,500
-648,570
| -39% | -$36.4M |
|
800
Black Hills Corp
BKH
$5.64B
| $55.5M | 0.01% |
1,099,455
-10,600
| -1% | -$535K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.